Silver Spring, MD, United States of America

Jonathan Schneck

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 200(Granted Patents)


Location History:

  • Silver Spring, MD (US) (2000 - 2024)
  • Baltimore, MD (US) (2019 - 2024)
  • Blatimore, MD (US) (2024)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jonathan Schneck: A Pioneer in Biodegradable Biomimetic Particles and Immunotherapy

Introduction: Jonathan Schneck, an accomplished inventor based in Silver Spring, MD, has made significant contributions to the field of biotechnology with a remarkable portfolio of 15 patents. His work primarily focuses on innovations that enhance immunotherapy and biocompatible materials aimed at improving human health.

Latest Patents: Among his latest patents, two stand out for their groundbreaking potential. The first patent addresses biodegradable biomimetic particles designed for interaction with immune cells. This invention incorporates a polymer blend of poly(lactic-co-glycolic acid) (PLGA) and poly(beta-amino ester) (PBAE). These particles are engineered with specific ligands to target various immune cell receptors, which could revolutionize the way we approach treatments for conditions involving the immune system, such as cancer.

The second noteworthy patent involves immunoswitch nanoparticles. This innovative technology aims to switch off immunosuppressive pathways found in tumor cells or cells infected by viruses, while concurrently activating co-stimulatory pathways on T cells. This dual action has promising implications for immunotherapy, representing a novel method for treating cancer and chronic viral infections.

Career Highlights: Jonathan Schneck is currently associated with The Johns Hopkins University, a prestigious institution known for its research-driven approach to science and medicine. His efforts have not only advanced scientific knowledge but have also opened new avenues for effective therapies that could transform patient care.

Collaborations: Throughout his career, Schneck has collaborated with talented individuals like Sean O'Herrin and Karlo Perica. Together, they form a dynamic team that contributes to the advancement of innovative research and patents, leveraging their collective expertise to push the boundaries of what is possible in medical science.

Conclusion: Jonathan Schneck stands out as a pioneering inventor in the fields of biotechnology and immunotherapy. His innovative patents and collaborative spirit exemplify the essence of modern scientific inquiry and have the potential to significantly impact the future of healthcare. His work continues to inspire the next generation of inventors and researchers striving for breakthroughs that can improve lives around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…